RECOVERY + WELLNESS
Wolverine
A combination of BPC-157 and TB-500 commonly discussed in recovery-focused peptide and wellness programs.
THE OVERVIEW
What is
Wolverine?
Wolverine is a commonly used name for a combination of two peptides, BPC-157 and TB-500. These compounds have been explored primarily in preclinical and research settings for their potential roles in biological processes associated with tissue repair and recovery.
BPC-157 and TB-500 are not FDA-approved drugs for treating injury, pain, or other medical conditions. A qualified medical professional should discuss the available evidence, uncertainties, potential risks, and appropriate alternatives before use is considered.
WHY IT MAY BE CONSIDERED
Why Wolverine Is Being Explored
01
Recovery Research
BPC-157 and TB-500 have been investigated in preclinical research involving biological processes associated with tissue repair and recovery.
02
Active-Lifestyle Interest
These peptides have attracted interest in recovery-focused and performance-wellness settings, although human clinical evidence remains limited.
03
Combination Approach
Wolverine combines BPC-157 and TB-500 into one commonly discussed peptide protocol rather than presenting either peptide individually.
PHYSICIAN-GUIDED CARE
Your treatment
is personal.
Peptide therapies require a different conversation from established FDA-approved medications. Your medical professional can review your goals, medical history, current medications, and the available evidence before discussing whether a peptide-based approach should be considered.
When discussing BPC-157 and TB-500, it is important to understand that evidence from human clinical trials is limited and that these peptides are not FDA-approved to diagnose, treat, cure, or prevent disease.
IMPORTANT INFORMATION
Understand the evidence.
BPC-157 and TB-500 are not FDA-approved drugs for treating injuries, accelerating healing, reducing pain, or treating other medical conditions. Much of the interest surrounding these peptides comes from laboratory, animal, and other preclinical research, and their safety and effectiveness for these uses have not been established through the type of human clinical evidence required for FDA approval.
Information on this page is educational and does not replace evaluation, diagnosis, or treatment by a licensed healthcare professional.
NEW FRONTIER MEDS